#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital nephrogenic diabetes insipidus Severe myoclonic epilepsy of infancy Deafness neurosensory Anti-myelin-associated glycoprotein associated polyneuropathy Squamous cell carcinoma of the oral cavity Autoimmune myositis Cardiac sarcoidosis Gaucher's disease type III Hypersomnia Stevens-Johnson syndrome Intracranial calcification Sexually transmitted disease Renal cell carcinoma Lung adenocarcinoma Vascular malformation More trials…

    Learn about Rare Diseases

    Brain stem glioma – Life with Disease Krabbe’s disease – Trials in Disease Undifferentiated sarcoma Angiosarcoma recurrent – Basic Information Fragile X syndrome – Treatment Piriformis syndrome – Trials in Disease Haemophilia A with anti factor VIII – Life with Disease Chondrosarcoma Hepatic angiosarcoma – Trials in Disease Amyotrophic lateral sclerosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    LYSERGIDE Octocog Alfa Tozorakimab IADADEMSTAT Maridebart Cafraglutide SILYMARIN Cyclophosphamide Mirvetuximab Soravtansine Balcinrenone Mesalazine Pralatrexate Paracetamol Dc Bidridistrogene Xeboparvovec Briquilimab IDOR-1117-2520C Atogepant Pegunigalsidase Alfa Venlafaxine Imiquimod Alternaria Alternata Extract More therapies…

    Learn about Your Condition

    Eye disorder Colorectal cancer stage IV Hip fracture Partial lipodystrophy Alveolar proteinosis Vertigo Pre-eclampsia Peritoneal cancer index Ulcerative keratitis Implantation complication Bone hypertrophy Athetosis Mucous membrane pemphigoid Meningioma malignant Drug use disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Multiprofile Hospital For Active Treatment…

University Multiprofile Hospital For Active Treatment Sofiamed OOD

Bulevard D-R G.m.dimitrov 16, Sofia, 1797, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • Study for Patients with Metastatic Colorectal Cancer with BRAF V600E Mutation Using Encorafenib, Cetuximab, and Chemotherapy Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Bevacizumab
    • Calcium Folinate
    • Capecitabine
    Belgium Bulgaria Czechia Denmark Finland Germany +7

  • Study of Anifrolumab for Adults with Moderate-to-Severe Systemic Lupus Erythematosus

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Anifrolumab
    Bulgaria Germany Hungary Poland Spain

  • Study on Safety and Efficacy of Bepirovirsen and Drug Combination for Chronic Hepatitis B in Patients on Nucleos(t)ide Analogue Therapy

    Not recruiting

    2 1
    Investigated Diseases:
    • Chronic hepatitis B
    • Hepatitis B
    Investigated Drugs:
    • Bepirovirsen
    • Gskvx000000008866
    • Gskvx000000008885
    Belgium Bulgaria France Germany Italy Poland +2

  • Study of Osimertinib and Chemotherapy for Patients with EGFR Mutation Positive Resectable Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Osimertinib
    Austria Bulgaria France Germany Italy Poland +1

  • Study of Tarlatamab for Patients with Limited-Stage Small-Cell Lung Cancer After Chemoradiotherapy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Argipressin
    • Betamethasone Sodium Phosphate
    • Buclizine Hydrochloride
    Austria Belgium Bulgaria France Germany Greece +6

  • Study of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels

    Not recruiting

    3 1
    Investigated Diseases:
    • Familial hypertriglyceridaemia
    • Hyperchylomicronaemia
    Investigated Drugs:
    • Isis 678354 Sodium Salt
    Bulgaria Czechia Denmark Finland France Germany +9

  • Study of Datopotamab Deruxtecan, Durvalumab, and Carboplatin for Advanced Non-Small Cell Lung Cancer in Patients Without Actionable Genomic Alterations

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Datopotamab Deruxtecan
    Austria Bulgaria France Germany Greece Hungary +4

  • Study on the Effectiveness of Retifanlimab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    • Squamous cell carcinoma of lung
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Paclitaxel
    Bulgaria Czechia

  • Study of Capivasertib and Abiraterone for Patients with Metastatic Hormone-Sensitive Prostate Cancer with PTEN Deficiency

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hormone-dependent prostate cancer
    Investigated Drugs:
    • Abiraterone Acetate
    • Capivasertib
    Belgium Bulgaria Czechia France Germany The Netherlands +3

  • Study on the Effectiveness and Safety of Gliclazide MR, Dapagliflozin, and Metformin for Patients with Type 2 Diabetes Not Well Controlled with Dapagliflozin

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Dapagliflozin
    • Gliclazide
    • Metformin
    Bulgaria Hungary Latvia Lithuania Poland
Previous Page
1 2 3 4 5
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!